EDWARDS LIFESCNS (EWL BE) stock market data APIs
€73.0155
0(0%)
as of December 17, 2025
Try our APIs with
free plan!
EDWARDS LIFESCNS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for EWL.BE.
Prev. Close
73.0155
Open
73.0155
High
73.0155
Low
73.0155
52 wk Range
59.62-74.79
Market Cap
67 356 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EDWARDS LIFESCNS data using free add-ons & libraries
Get EDWARDS LIFESCNS Fundamental Data
EDWARDS LIFESCNS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EDWARDS LIFESCNS News
New
Is There Now An Opportunity In Edwards Lifesciences Corporation (NYSE:EW)?
Today we're going to take a look at the well-established Edwards Lifesciences Corporation (NYSE:EW). The company's stock saw a decent share price growth of 14% on the NYSE over the last few months. Th...
Exploring Global Markets With 3 Undervalued Small Caps And Insider Activity
As global markets navigate the anticipation of an interest rate cut from the Federal Reserve, small-cap stocks have shown resilience, with the Russell 2000 Index advancing amid a backdrop of mixed eco...
Should You Continue to Hold EW Stock in Your Portfolio?
Edwards Lifesciences Corporation EW is well-poised to grow in the coming quarters owing to its Surgical Structural Heart, which pioneered the RESILIA tissue. The company’s Transcatheter Aortic Valve...
Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative?
Edwards Lifesciences’ recent Investor Day outlined upgraded 2025 revenue growth expectations of about 9%–10% and introduced 2026 adjusted EPS guidance of US$2.80–US$2.95, alongside anticipated c...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
